Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24‐week, Randomized, Double‐Blind Parallel‐Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily)

AIMS: To compare the once‐daily rivastigmine patch 9.5 mg/24 h (10 cm(2)) versus twice‐daily capsule (12 mg/day) in Chinese patients with probable Alzheimer's disease (AD) (mini‐mental state examination [MMSE] scores of 10–20). METHODS: The primary objective was to demonstrate the noninferiorit...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:CNS Neurosci Ther
Hlavní autoři: Zhang, Zhen‐Xin, Hong, Zhen, Wang, Yan‐Ping, He, Li, Wang, Ning, Zhao, Zhong‐Xin, Zhao, Gang, Shang, Lan, Weisskopf, Marianne, Callegari, Francesca, Strohmaier, Christine
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492844/
https://ncbi.nlm.nih.gov/pubmed/27012596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12521
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky